Lung adenocarcinoma (LUAD), a leading type of non-small cell lung cancer, exhibits considerable molecular diversity due to genetic, epigenetic, and transcriptomic alterations, which affect tumour progression, treatment efficacy, and prognosis. This study syste... ...

请注册登录后继续浏览